300 related articles for article (PubMed ID: 35860284)
1. Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.
Chen Y; Tang X
Front Immunol; 2022; 13():890142. PubMed ID: 35860284
[TBL] [Abstract][Full Text] [Related]
2. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
Julio PR; Cortês MMM; Costallat LTL; Gaino JZ; França MC; Appenzeller S
Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
[TBL] [Abstract][Full Text] [Related]
4. A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation.
Colucci G; Pabst T; Bacher U; Maggioli C; Zecca C; Gobbi C
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32934013
[No Abstract] [Full Text] [Related]
5. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity.
Calixto OJ; Poveda S; Meneses-Toro MA; Vera-Parra EC; Romero-Sánchez C; Guzman Molano LF; Bello-Gualtero JM
Lupus; 2023 Aug; 32(9):1123-1125. PubMed ID: 37369195
[TBL] [Abstract][Full Text] [Related]
6. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
[TBL] [Abstract][Full Text] [Related]
7. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
[TBL] [Abstract][Full Text] [Related]
8. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Dyck PJB; Tracy JA
Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
[TBL] [Abstract][Full Text] [Related]
9. Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients.
Alkhawajah NM; Dunnigan SK; Bril V
J Neurol; 2014 Aug; 261(8):1485-91. PubMed ID: 24801490
[TBL] [Abstract][Full Text] [Related]
10. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy.
Simmons Z; Albers JW; Bromberg MB; Feldman EL
Neurology; 1993 Nov; 43(11):2202-9. PubMed ID: 8232929
[TBL] [Abstract][Full Text] [Related]
11. [A case of chronic inflammatory demyelinating polyradiculoneuropathy concomitant with acquired von Willebrand syndrome].
Ueda M; Kawamura N; Tateishi T; Shigeto H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2011 May; 51(5):334-7. PubMed ID: 21706830
[TBL] [Abstract][Full Text] [Related]
12. Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders.
Byun JM; Kwon YN; Koh Y; Yoon SS; Sung JJ; Kim I
Sci Rep; 2019 Nov; 9(1):16769. PubMed ID: 31727997
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
Bromberg MB; Feldman EL; Albers JW
Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
[TBL] [Abstract][Full Text] [Related]
14. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
Ramchandren S; Lewis RA
Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
[TBL] [Abstract][Full Text] [Related]
15. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
Allen JA; Bril V
Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in immune-mediated inflammatory neuropathies.
Martín-Aguilar L; Pascual-Goñi E; Querol L
Med Clin (Barc); 2019 Nov; 153(9):360-367. PubMed ID: 31443948
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy.
Hu N; Niu J; Liu M
Neurol Sci; 2022 Oct; 43(10):5885-5898. PubMed ID: 35737187
[TBL] [Abstract][Full Text] [Related]
18. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
19. Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Abraham A; Alabdali M; Qrimli M; Albulaihe H; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
PLoS One; 2015; 10(10):e0139674. PubMed ID: 26461125
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of CIDP in patients with diabetes or CMT1.
Latov N
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():14-7. PubMed ID: 21696491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
